Rein Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.14

+0.00 (+0.00%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +4,018.4% upside

Low Target $33.28

Average Target $46.95

High Target $64.49

Current Price $1.14

Current
$1.14

Target
$46.95

$33.28 $46.95 avg $64.49

Scenario Analysis

Bear Case

$33.28

2,819.3%

Low target

Base Case

$46.95

+4,018.4%

Avg target

Bull Case

$64.49

+5,557.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$49.35

-97.7% from high

52-Week Low

$22.96

+-95.0% from low

Target vs 52W High

$46.95

-4.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%